The Low-Dose Peptide I Take

🩺 Get your personalized health plan: https://drstanfield.com 💊 Supplements I Take: https://drstanfield.com/pages/my-supplements 💊MicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus 💊MicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin Timestamps: 00:00 Discovery of GLP-1 and Weight Loss Effects 01:33 Cardiovascular and Kidney Benefits of GLP-1 02:45 GLP-1 Medications and Cancer Progression 02:51 GLP-1 Medications and Joint Health 06:39 Benefits of GLP-1 and GIP Combination 08:57 Why Tirzepatide Over Retatrutide 09:52 My Personal Experience with Tirzepatide 10:23 Safety Concerns ✔️ X: https://x.com/BradStanfieldMD ✔️ Patreon: https://www.patreon.com/bradstanfieldmd Here are the links to the research papers referenced in the video: SELECT (Lincoff 2023) — https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 FLOW (Perkovic 2024) — https://www.nejm.org/doi/10.1056/NEJMoa2403347 SURPASS-CVOT primary (Nicholls 2025) — https://www.nejm.org/doi/abs/10.1056/NEJMoa2505928 Exenatide history (Wikipedia) — https://en.wikipedia.org/wiki/Exenatide SCALE (Pi-Sunyer 2015) — https://www.nejm.org/doi/full/10.1056/NEJMoa1411892 STEP 1 (Wilding 2021) — https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 ASCO 2026 — GLP-1 + cancer progression — https://www.oncology-central.com/asco-2026-glp-1s-could-reduce-the-risk-of-some-obesity-related-cancers-progressing/ Cartilage regeneration review — https://pmc.ncbi.nlm.nih.gov/articles/PMC10071204/ Weight loss → knee-joint load (Messier 2005) — https://pubmed.ncbi.nlm.nih.gov/15986358/ STEP 9 (semaglutide + knee OA) — https://www.nejm.org/doi/abs/10.1056/NEJMoa2403664 Chen pair-fed mice / semaglutide + OA (Cell Metabolism 2026) — https://www.cell.com/cell-metabolism/fulltext/S1550-4131(26)00008-2 Di Chen quote — CGTN — https://news.cgtn.com/news/2026-02-12/-Weight-loss-wonder-drug-can-also-treats-osteoarthritis-study-finds-1KHcUiXzHsQ/p.html ESSENCE (Sanyal 2025, MASH) — https://www.nejm.org/doi/full/10.1056/NEJMoa2413258 Klausen Lancet (semaglutide + AUD, 2026) — https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3 Retatrutide Phase 2 (Jastreboff 2023) — https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Tirzepatide vs Semaglutide HR — https://www.nejm.org/doi/full/10.1056/NEJMoa2107519 Pancreatitis meta-analysis — https://pubmed.ncbi.nlm.nih.gov/32720500/ Thyroid cancer + semaglutide review — https://pmc.ncbi.nlm.nih.gov/articles/PMC11050669/ FDA suicide signal evaluation (Jan 2024) — https://www.fda.gov/drugs/drug-safety-communications/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type GLP-1 calorie-intake reduction — https://pmc.ncbi.nlm.nih.gov/articles/PMC11340591/ Mozaffarian 2025 Joint Advisory (multivitamin-mineral recommendation) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12304835/ MicroVitamin Labdoor review (99.7%) — https://labdoor.com/review/dr-brad-stanfield-microvitamin Thumbnail by James Kelly Video edited by Troy Young Script by John Milliken The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.